Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

By Okamoto Isamu   Miyazaki Masaki   Morinaga Ryotaro   Kaneda Hiroyasu   Ueda Shinya   Hasegawa Yoshikazu   Satoh Taroh   Kawada Akira   Fukuoka Masahiro   Fukino Koichi   Tanigawa Takahiko   Nakagawa Kazuhiko  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 844-853

Springer Publishing Company

Access to resources Recommend Favorite

Clinical next-generation sequencing in patients with non–small cell lung cancer

By Hagemann Ian S.   Devarakonda Siddhartha   Lockwood Christina M.   Spencer David H.   Guebert Kalin   Bredemeyer Andrew J.   Al-Kateb Hussam   Nguyen TuDung T.   Duncavage Eric J.   Cottrell Catherine E.   Kulkarni Shashikant   Nagarajan Rakesh   Seibert Karen   Baggstrom Maria   Waqar Saiama N.   Pfeifer John D.   Morgensztern Daniel   Govindan Ramaswamy  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 631-639

Blackwell Publishing

Access to resources Recommend Favorite

Taxanes for advanced non-small cell lung cancer

By Ramalingam Sakkaraiappan   Belani Chandra P  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1693-1709

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed in advanced non-small cell lung cancer

By Gridelli Cesare   Maione Paolo   Rossi Antonio   Bareschino Maria Anna   Schettino Clorinda   Sacco Paola Claudia   Zeppa Rosario  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-enriched Sequencing in Chinese Patients with Advanced Non-small Cell Lung Cancer

By Jiang B   Liu F   Yang L   Zhang W   Yuan H   Wang J   Huang G  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1392-1401

Field House Publishing

Access to resources Recommend Favorite